Literature DB >> 27163191

Chronic variable stress and intravenous methamphetamine self-administration - Role of individual differences in behavioral and physiological reactivity to novelty.

S B Taylor1, L R Watterson2, P R Kufahl2, N E Nemirovsky2, S E Tomek2, C D Conrad3, M F Olive4.   

Abstract

Stress is a contributing factor to the development and maintenance of addiction in humans. However, few studies have shown that stress potentiates the rewarding and/or reinforcing effects of methamphetamine in rodent models of addiction. The present study assessed the effects of exposure to 14 days of chronic variable stress (CVS), or no stress as a control (CON), on the rewarding and reinforcing effects of methamphetamine in adult rats using the conditioned place preference (Experiment 1) and intravenous self-administration (Experiment 2) paradigms. In Experiment 2, we also assessed individual differences in open field locomotor activity, anxiety-like behavior in the elevated plus maze (EPM), and physiological responses to a novel environment as possible predictors of methamphetamine intake patterns. Exposure to CVS for 14 days did not affect overall measures of methamphetamine conditioned reward or reinforcement. However, analyses of individual differences and direct vs. indirect effects revealed that rats exhibiting high physiological reactivity and locomotor activity in the EPM and open field tests self-administered more methamphetamine and reached higher breakpoints for drug reinforcement than rats exhibiting low reactivity. In addition, CVS exposure significantly increased the proportion of rats that exhibited high reactivity, and high reactivity was significantly correlated with increased levels of methamphetamine intake. These findings suggest that individual differences in physiological and locomotor reactivity to novel environments, as well as their interactions with stress history, predict patterns of drug intake in rodent models of methamphetamine addiction. Such predictors may eventually inform future strategies for implementing individualized treatment strategies for amphetamine use disorders.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic stress; Individual differences; Locomotor; Methamphetamine; Place preference; Reactivity; Self-administration

Mesh:

Substances:

Year:  2016        PMID: 27163191      PMCID: PMC4912961          DOI: 10.1016/j.neuropharm.2016.05.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  62 in total

1.  An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program.

Authors:  Kevin W Chen; Annie N Banducci; Leila Guller; Richard J Macatee; Anna Lavelle; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

2.  Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis.

Authors:  M S Hooks; A C Colvin; J L Juncos; J B Justice
Journal:  Brain Res       Date:  1992-08-07       Impact factor: 3.252

3.  Chronic stress impairs spatial memory and motivation for reward without disrupting motor ability and motivation to explore.

Authors:  Jonathan K Kleen; Matthew T Sitomer; Peter R Killeen; Cheryl D Conrad
Journal:  Behav Neurosci       Date:  2006-08       Impact factor: 1.912

Review 4.  What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus?

Authors:  Cheryl D Conrad
Journal:  Behav Cogn Neurosci Rev       Date:  2006-03

5.  Early life stress and chronic variable stress in adulthood interact to influence methamphetamine self-administration in male rats.

Authors:  Candace R Lewis; Kelsey Staudinger; Seven E Tomek; Raymundo Hernandez; Tawny Manning; M Foster Olive
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

6.  Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats.

Authors:  Sara B Taylor; Julie A Markham; Adam R Taylor; Brooke Z Kanaskie; James I Koenig
Journal:  Behav Brain Res       Date:  2011-05-19       Impact factor: 3.332

7.  Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress.

Authors:  S Bhatnagar; M Dallman
Journal:  Neuroscience       Date:  1998-06       Impact factor: 3.590

8.  Locomotor activity in a novel environment predicts both responding for a visual stimulus and self-administration of a low dose of methamphetamine in rats.

Authors:  Amy M Gancarz; Michele A San George; Lisham Ashrafioun; Jerry B Richards
Journal:  Behav Processes       Date:  2011-01-05       Impact factor: 1.777

9.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

10.  Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats.

Authors:  M D S Lapiz-Bluhm; C O Bondi; J Doyen; G A Rodriguez; T Bédard-Arana; D A Morilak
Journal:  J Neuroendocrinol       Date:  2008-07-30       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.